Browse By: Country ι Category ι Tag

Burkitt Lymphoma Global Clinical Trials Review, H2, 2012

Pages » 84
Published By » GlobalData
Price » $2500
In stock
View Report Details
Description

Burkitt Lymphoma Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, Burkitt Lymphoma Global Clinical Trials Review, H2, 2012" provides data on the Burkitt Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Burkitt Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burkitt Lymphoma.... Click here for more details


Non-Hodgkins Lymphoma (NHL) - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist has released a new report, Non-Hodgkins Lymphoma (NHL) Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global NHL market. The report identifies the key trends shaping and driving the g
Published Date: Nov 2010
Price: $2000
US Oncologist Survey: Optimizing Treatment for Stage IIIA Asymptomatic Indolent Lymphoma
Patient specific case scenario on advanced non-Hodgkin’s lymphoma in a situation involving a patient with Stage IIIA Asymptomatic Indolent Lymphoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patien
Published Date: Apr 2011
Price: $2999
US Oncologist Survey: Optimizing Treatment for Large Cell Lymphoma
Two patient specific case scenarios on advanced non-Hodgkin’s lymphoma involving patients with a) relapsed large cell lymphoma and b) large cell lymphoma with compromised cardiac function that progresses throughout the report, presented to 158 high-prescribing oncologists for their ope
Published Date: Apr 2011
Price: $2999
US Oncologist Survey: Optimizing Treatment for Stage IV Follicular B-Cell Non-Hodgkin\'s Lymphoma
A patient specific case scenario on advanced non-Hodgkin’s lymphoma involving a patient with stage IV follicular B-cell that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progressions reveal: &n
Published Date: Apr 2011
Price: $2999
US Oncologist Survey: Optimizing Treatment for Advanced Non-Hodgkin\'s Lymphoma
Experience real patient situations that progressively unfold, presented to a representative sample of 158 US oncologists who manage 11 or more patients monthly with non-Hodgkin’s lymphoma. Oncologists were presented with four patient case scenarios and asked to respond to open-ended ques
Published Date: Apr 2011
Price: $8900
Diffuse Large B-cell Lymphoma Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, Q4, 2010" provides data on the Diffuse Large B-Cell Lymphoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Diffuse Large B-Cell Lymphoma
Published Date: Dec 2010
Price: $1000
B-cell Lymphomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, “B-Cell Lymphomas Global Clinical Trials Review, Q4, 2010"" provides data on the B-Cell Lymphomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on B-Cell Lymphomas. It includes an overview of th
Published Date: Dec 2010
Price: $1000
T-cell Lymphomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, Q4, 2010"" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of th
Published Date: Dec 2010
Price: $1000
Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, Q4, 2010"" provides data on the Mantle Cell Lymphoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Mantle Cell Lymphoma. It includes an ov
Published Date: Dec 2010
Price: $1000
Follicular Lymphoma Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, Q4, 2010"" provides data on the Follicular Lymphoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Follicular Lymphoma. It includes an overv
Published Date: Dec 2010
Price: $1000

 


 

Related News

Hygiene Hypothesis Corroborates Spike in Demand for Allergy Diagnostics
The global allergy diagnostic market has been booming over the past few years due to a proposed hygiene hypothesis. The theory claims that lack of exposure to allergens and dust or living in excessively hygienic conditions can make the human body prone to allergies as the immune system does not learn to fight. This theory has been proposed to back the increasing number of asthma cases amongst children, especially in the developed countries, where hygiene is given importance above its due. In add
Date: Oct 24

Globally Warming to Encourage Spread of Lethal Bacteria in Oceans Globally
It has already become evident that the increasing ocean temperatures have been making individuals sick and this is only becoming worse now. The bacteria that loves warmth is now growing in large numbers and is posing disastrous impacts on the human health, as per a study published recently. The bacteria called as Vibrio bacteria has caused around eighty thousand illnesses as well as about hundred deaths within the U.S alone in the past few years. Exceptional Count of Vibrio Cases in Northern Eu
Date: Aug 10

Global Paracetamol and PAP Market Fights an Uphill Battle
Paracetamol has been one of the most commonly used drugs in modern medicine. It has been used in the treatment of the most common ailments, including fever, cold, arthritis, and also major epidemics such as the swine flu. Consumers have shown a high rate of consumption of paracetamol as it provides almost instant relief from symptoms, is available everywhere as a generic drug, and is available as an over the counter drug in most countries. This includes the nations in North America, where the co
Date: Feb 18

Next-generation Antifungal Drugs Hold Promise for Dermatophytoses, Newer Therapeutics Overcome Shortcomings of Early Drugs
In the U.S., onychomycosis poses as a major public health problem, as it is prevalent in 10% of the population and its associated morbidity. Although not life-threatening, the fungal infection is a dermatophytic invasion of the nail plate. The infection can be present in any component of the nail unit, which includes the bed, matrix, or plate. Pain, discomfort, and disfigurement are the notable signs of onychomycosis, which may lead to significant physical and occupational limitations. The condi
Date: Jan 25

Despite Rise in Number of Erectile Dysfunction Cases, Revenue Generation from ED Drugs to Decline
This is probably one of the few times when availability of certain drugs is actually hampering the growth of a certain section of the health care market. The erectile dysfunction drugs market, over the past few decades, has been driven by the rising incidence of erectile dysfunction caused by environmental and genetic factors. However, there are several forces in the coming years that are anticipated to negatively impact the erectile dysfunction drugs market, causing it to register a -4.50 per c
Date: Jan 22

Chipotle and Costco E.coli Outbreaks Point out the Need for Advanced Testing Kit
During the period from October 2015 to November 2015, over 50 customers have been affected with E.coli after eating at Chipotle locations across Washington, Kansas, Oregon, and Oklahoma. More recently, 80 college students in Boston fell sick with the norovirus after contracting it from a single Chipotle location. By the end of 2015, more than 350 people became sick after eating at Chipotle. In early November, just after the Chipotle case had made headlines, another E.coli outbreak was reported i
Date: Jan 20

What the Newly Found Ebola Antibodies Mean for the Healthcare Industry
In what could be perceived to be one of the greater breakthroughs in the field of medicine, researchers have engineered the first antibodies that have the ability to neutralize two strains of the deadly Ebola-causing virus. The research was conducted on mice and is considered to be a major step in achieving immunization against all strains of Ebola. The research was led by Dr. Jonathan Lai. He stated that it is a tremendous advance to achieve a broadly effective Ebola immunotherapy. This is bec
Date: Jan 14

California Considering Exempting ‘Tampon Tax’
Growing awareness towards sanitation and urbanization has boosted the demand from the global feminine hygiene products market. In regions, especially Asia Pacific, several health programs focussed to raise awareness about sanitation across rural areas has augmented the market growth. Key market players such as Proctor & Gamble and Johnson & Johnson have partnered with governments in countries such as India to increase awareness among women regarding menstruation related health concerns. Rising c
Date: Jan 12

Aurobindo Pharma Latest to Join Line of Generic Drug Makers of Norethindrone Acetate
The United States Food and Drugs Association has officially given the nod of approval to Aurobindo Pharma to manufacture, sell, and market generic variants of norethindrone acetate within the U.S. market. The U.S. health regulator has provided Aurobindo Pharma with the vital agreement to create 5 mg strength tablets of norethindrone acetate, as said by an Aurobindo Pharma spokesperson in a recent statement. They later added that the drug has an estimated market size of US$42 mn for the twelve m
Date: Jan 11

Oral Contraceptive Pills Market Witnessing Surging Demand Particularly from Developed Regions
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.  Among the most prominent brands available in the market Loestrin and Bay
Date: Jan 07

Upcoming Reports

Lymphoma Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Lymphoma is a kind of blood cancer which occurs when B or T lymphocytes and leukocytes grow abnormally. In addition, it also occurs if these cells survive longer than their normal life cycle. Lymphoma generally occurs in lymph nodes, bone marrow, spleen, blood and other organs which form a part of t
Published By: Transparency
Price: $5795
Large Cell Lymphoma Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
Lymphoma is a major type of cancer. Lymphoma is a group of blood cancer, in which the blood cells, particularly, lymphocytes grow and divide very rapidly than normal rate. It is supported by enhanced duration of life of blood cells than that of a normal person. In most of the cases, lymphoma is pres
Published By: Transparency
Price: $5795
Non-Hodgkins Lymphoma (NHL) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Lymphoma is one of the most hazardous and life threatening type of cancer, related to lymphocytes, an important type of white blood cells. Non-Hodgkin’s lymphomas (NHL) is a distinct group of blood cancer, which includes large variety of lymphomas, excluding Hodgkin’s lymphomas. Non-Hodg
Published By: Transparency
Price: $5795
Lymphoblastic Lymphoma Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Lymphobalstic lymphoma is also known as non-hodgkin lymphoma a type of cancer that primarily affects lymphatic system. The lymphatic system comprises organs such as the thymus, bone marrow, spleen, and the lymph nodes (or lymph glands). Lymph nodes are connected by a network of tubes called lymphati
Published By: Transparency
Price: $5795
CNS Lymphoma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Central Nervous System (CNS) lymphoma is also known as primary CNS lymphoma and microglioma, is a type of intracranial tumor observed in patients diagnosed with severe immunosupression (typically patients with AIDS). Primary CNS lymphoma initiates in the spinal cord, brain or meninges. While, most o
Published By: Transparency
Price: $5795